Pharmaceutical
Indications

 

38 Results were found on Technologies

Leading Researchers:

BiPS for the treatment of Diabetes

Additional information can be provided upon request. Read More >

Leading Researchers:

Biomarkers for risk assessment in colorectal cancer patients

Mortalin (also known as GRP75 and mitochondrial stress protein 70) is a ubiquitously expressed mitochondrial chaperone related to the cytosolic heat shock protein 70 (HSP70). It protects cells from senescence and apoptosis and is overexpressed in... Read More >

Leading Researchers:

REGULATION OF AMYLOID BETA MOLECULAR COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE

THE NEED Currently available treatment options for AD are symptomatic and do not modify the progression of the disease. This disease-modifying technology achieves previously unattainable blockage of cognitive deterioration in AD. The technology... Read More >

Leading Researchers:

Antibodies and molecular recognition

"M2", a novel cysteine constrained looped 14-amino acid peptide, has been developed and optimized to bind HIV gp120. M2 binding allosterically elicits conformational rearrangements in the structure of HIV gp120 revealing the "CD4 induced"... Read More >

Leading Researchers:

Novel Integrase Based Cancer Treatment Technology

We have developed a new gene therapy technology for specific cancer cells killing and validated both efficacy and safety superiority of the proposed system over the conventional one in lung cancer mice model. The proposed system offers advantages... Read More >

Leading Researchers:

Enzyme replacement therapy for lysosomal storage diseases

Lysosomal Storage diseases (LSD) are inherited genetic defects, resulting in an enzyme deficiency. This deficiency prevents the lysosome from metabolizing cellular waste, and results in their accumulation in the cell. Excessive storage of... Read More >

Leading Researchers:

Compositions for treating ophthalmic medical conditions

Additional information can be provided upon request. Read More >

Leading Researchers:

miRNA for the treatment of Melanoma

Additional information can be provided upon request. Read More >

Leading Researchers:

Multifunctional 5-aminolevulinic acid prodrugs activating 5 diverse cell-death pathways

The present invention provides drug conjugates comprising 5-aminolevulinic acid (ALA), an aldehyde and a carboxylic acid that may function as a histone deacetylase inhibitor (HDACI). These conjugates may serve as co-drugs which release a plurality... Read More >

Leading Researchers:

Targeting of siRNA to tumors and their stroma

TechnologyTumor-directed in vivo delivery of miRNA and siRNA by novel dendritic nanocarriers was developed. The invention is based on a novel polyglycerols (PG)-based dendrimer core–shell structure that delivers miRNA/siRNA in vivo to tumors and... Read More >